Literature DB >> 18007490

Fused heterocycles: synthesis of some new imidazo[1,2-a]- pyridine derivatives.

Birgul Ozden Kasimogullari1, Zafer Cesur.   

Abstract

Some new thiazolidines and spirothiazolidines derived from hydrazones of 2-methylimidazo[1,2-a]pyridine-3-carboxylic acid hydrazide, a bioisosteric derivative of isoniazid, were synthesized and characterized by analytical, IR, (1)H- and (13)C-NMR and mass spectral data. Some of the newly synthesized compounds were screened for their antimycobacterial activities. None of the tested compounds showed significant in vitro antituberculous activity at 6.25 mirog/mL (MIC rifampin 0.031 microg/mL).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 18007490      PMCID: PMC6148530          DOI: 10.3390/91000894

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  2 in total

1.  Synthesis and antituberculosis activity of some new 2-quinoxalinecarbonitriles.

Authors:  M E Montoya; Y Sainz; M A Ortega; A Lopez De Cerain; A Monge
Journal:  Farmaco       Date:  1998 Aug-Sep

2.  Synthesis of some new 6-methylimidazo[2,1-b]thiazole-5-carbohydrazide derivatives and their antimicrobial activities.

Authors:  Füsun Ur; Nesrin Cesur; Seher Birteksöz; Gülten Otük
Journal:  Arzneimittelforschung       Date:  2004
  2 in total
  6 in total

1.  Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.

Authors:  Garrett C Moraski; Lowell D Markley; Philip A Hipskind; Helena Boshoff; Sanghyun Cho; Scott G Franzblau; Marvin J Miller
Journal:  ACS Med Chem Lett       Date:  2011-06-09       Impact factor: 4.345

2.  4-Benzyl-8-phenyl-1-thia-4-aza-spiro-[4.5]decan-3-one.

Authors:  Hoong-Kun Fun; Tze Shyang Chia; Poovan Shanmugavelan; Alagusundaram Ponnuswamy
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-04-18

Review 3.  Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis.

Authors:  Erik J Hasenoehrl; Thomas J Wiggins; Michael Berney
Journal:  Front Cell Infect Microbiol       Date:  2021-01-11       Impact factor: 5.293

4.  On drug discovery against infectious diseases and academic medicinal chemistry contributions.

Authors:  Yves L Janin
Journal:  Beilstein J Org Chem       Date:  2022-09-29       Impact factor: 2.544

5.  Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB.

Authors:  Katherine A Abrahams; Jonathan A G Cox; Vickey L Spivey; Nicholas J Loman; Mark J Pallen; Chrystala Constantinidou; Raquel Fernández; Carlos Alemparte; Modesto J Remuiñán; David Barros; Lluis Ballell; Gurdyal S Besra
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

6.  Design and synthesis of novel Imidazo[2,1-b]thiazole derivatives as potent antiviral and antimycobacterial agents.

Authors:  Elif Gürsoy; Efe Doğukan Dincel; Lieve Naesens; Nuray Ulusoy Güzeldemirci
Journal:  Bioorg Chem       Date:  2019-12-06       Impact factor: 5.275

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.